<DOC>
	<DOCNO>NCT00402883</DOCNO>
	<brief_summary>The purpose study see combination chemotherapy plus radiation therapy immunotherapy ( bevacizumab ) expand treatment option patient non-small cell lung cancer .</brief_summary>
	<brief_title>Chemotherapy , Radiotherapy Bevacizumab Patients With Unresectable Stage III Non-Small-Cell Lung Cancer</brief_title>
	<detailed_description>The patient study receive treatment 3 stage therapy . The first stage Induction Therapy . This therapy 7 week long . Patients receive bevacizumab follow pemetrexed follow carboplatin vein week week 1 4 . During Induction patient also receive radiation therapy daily , Monday Friday , 7 week ( week 1-7 ) . This follow 2 week rest . During rest period patient scan do see disease respond treatment . The next stage treatment Consolidation Therapy . This stage 10 week long . Patients receive bevacizumab follow pemetrexed follow carboplatin vein week week 10 , 13 16 . This follow 3 week rest . During week 19 patient scan see disease respond treatment . The last stage treatment Maintenance Therapy . Patients receive bevacizumab alone vein every 3 week . Treatment give every three week 9 treatment . ( week 45 )</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Clinically confirm nonsmall cell lung cancer stage IIIA select stage IIIB Measurable evaluable disease Be able care self Adequate kidney , liver bone marrow function No prior treatment disease Must able give write informed consent Must able take folic acid , vitamin B12 dexamethasone describe protocol Age 18 year old Stage IV IIIB patient pleural pericardial effusion Stage IIIB disease contralateral mediastinal node great 4cm Squamous cell predominant tumor Pregnant lactate woman Patients active infection History another cancer within last 5 year exception skin cancer cervical carcinoma situ History stroke , transient ischemic attack , acute MI within past 6 month serious cardiovascular disease Symptoms peripheral vascular disease History neurological disease Recent history blood sputum vomitus Nonhealing wound , ulcer long bone fracture History bleed problem coagulation problem History abdominal fistula , gastrointestinal perforation intraabdominal abscess within 6 month History uncontrolled hypertension Chronic use nonsteroidal antiinflammatory medication allow study Please note : There additional inclusion/exclusion criterion . The study center determine meet criterion . If qualify trial , study personnel explain reason . If qualify , study personnel explain trial detail answer question may . You decide wish participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>